CN102512593B - Traditional Chinese medicine preparation for treating aplastic anemia - Google Patents

Traditional Chinese medicine preparation for treating aplastic anemia Download PDF

Info

Publication number
CN102512593B
CN102512593B CN 201110460080 CN201110460080A CN102512593B CN 102512593 B CN102512593 B CN 102512593B CN 201110460080 CN201110460080 CN 201110460080 CN 201110460080 A CN201110460080 A CN 201110460080A CN 102512593 B CN102512593 B CN 102512593B
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
semen
aplastic anemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201110460080
Other languages
Chinese (zh)
Other versions
CN102512593A (en
Inventor
黄传峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201110460080 priority Critical patent/CN102512593B/en
Publication of CN102512593A publication Critical patent/CN102512593A/en
Application granted granted Critical
Publication of CN102512593B publication Critical patent/CN102512593B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a traditional Chinese medicine preparation for treating aplastic anemia. The aplastic anemia can belong to the category of blood deficiency, blood depletion, consumptive disease and the like in the traditional Chinese medical science. Symptomatic treatment is adopted in the hospital, i.e. traditional Chinese medicines with effects of tonifying spleen and kidney, tonifying qi and nourishing blood are selected, such as Codonopsis pilosula, bighead atractylodes rhizome, Rhodiola rosea, Schisandra chinensis, Eucommia ulmoides, chaff flower root, wolfberry fruit, semen canavaliae, Semen sesami nigrum, sophora flower, rhizoma polygonati, semen cassiae and arillus longan, and the traditional Chinese medicines are prepared into a decoction for patients to take. Proved by clinical tests of the hospital, the total effective rate is 93.3 percent, and is obviously superior to that of a control group. Moreover, the traditional Chinese medicine preparation for treating the aplastic anemia does not have toxic and side effects after being taken for a long time, and is low in treatment cost.

Description

A kind of Chinese medicine preparation for the treatment of aplastic anemia
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine preparation for the treatment of aplastic anemia.
Background technology
Chronic aplastic anemia is one group of marrow hematopoiesis function failure that is caused by Different types of etiopathogenises, and the intractable hematopathy take hematopoietic stem cell injuries, peripheral blood pancytopenia as feature often shows as anemia, hemorrhage and infect clinically; Usually lassitude, tired rear tachypnea, cardiopalmus, dizziness, pale complexion.If any hemorrhage also slighter, visceral hemorrhage is more rare.Infect, heating is generally slighter, occur more late, more easy to control after treatment.Liver, all not enlargements of splenic lymph nodes have the spleen silght enlargement but late case is even, and the course of disease is longer, and the patient can survive for many years, and the state of an illness takes a turn for the better gradually and even approaches recovery from illness.
The method of conventional therapy chronic aplastic anemia has a variety of, mainly contain operative treatment, adrenocortical hormone therapy, the operative treatment wound is larger, Long-term Hormone, as oral immunity inhibitor cyclosporin A etc., side effect is large, as liver function injury, edema, body weight increase, acne etc.Taking the Chinese medicine symptomatic treatment is a kind of effective method.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine preparation for the treatment of aplastic anemia.Aplastic anemia can belong to the categories such as " blood deficiency ", " blood depletion ", " asthenia " in Chinese medicine, the traditional Chinese medical science adopts symptomatic treatment, take tonifying speen and tonifying kidney, benefiting QI and nourishing blood as the rule for the treatment of.
The objective of the invention is to be achieved through the following technical solutions, the Chinese medicine preparation of this treatment aplastic anemia is made by the Chinese medicine of following weight portion: Radix Codonopsis 7-12 part, Rhizoma Atractylodis Macrocephalae 10-15 part, Radix Rhodiolae 6-10 part, Fructus Schisandrae Chinensis 6-10 part, Cortex Eucommiae 9-13 part, Radix Achyranthis Bidentatae 10-15 part, Fructus Lycii 9-14 part, Semen Canavaliae 5-7 part, Semen Sesami Nigrum 7-12 part, Flos Sophorae 10-15 part, Rhizoma Polygonati 5-9 part, Semen Cassiae 5-7 part, Arillus Longan 9-13 part.
Preferably, the Chinese medicine preparation of this treatment aplastic anemia is made by the Chinese medicine of following weight portion: 10 parts of Radix Codonopsis, 13 parts of the Rhizoma Atractylodis Macrocephalaes, 8 parts of Radix Rhodiolaes, 8 parts of Fructus Schisandrae Chinensis, 11 parts of the Cortexs Eucommiae, 13 parts of Radix Achyranthis Bidentataes, 12 parts of Fructus Lycii, 6 parts of Semen Canavaliaes, 9 parts of Semen Sesami Nigrums, 13 parts, Flos Sophorae, 7 parts of Rhizoma Polygonatis, 6 parts of Semen Cassiaes, 11 parts of Arillus Longans.
Radix Codonopsis invigorating the spleen and replenishing QI in the side, the spleen invigorating lung benefiting; Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, hidroschesis is antiabortive; The Radix Rhodiolae benefiting QI for activating blood circulation is promoted blood circulation and is relievingd asthma; The Fructus Schisandrae Chinensis convergence is astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, kidney calming; Cortex Eucommiae invigorating middle warmer benefit essence, invigorating the liver and kidney, bone and muscle strengthening; The Radix Achyranthis Bidentatae nourishing the liver and kidney, bone and muscle strengthening; The Fructus Lycii invigorating the liver and kidney, benefiting essence-blood; The Semen Canavaliae warming the middle warmer and descending qi, the kidney tonifying complement; The Semen Sesami Nigrum the liver and the kidney tonifying is moisturized spermatogenesis; The Flos Sophorae purging liver-fire, cooling blood for hemostasis; The Rhizoma Polygonati boosting qi and nourishing yin, tonifying speen and tonifying kidney; Semen Cassiae liver heat removing tomorrow, constipation relieving and the intestine moistening; The Arillus Longan invigorating the heart and spleen, nourishing blood to tranquillize the mind.
Above-mentioned Chinese medicine is made decoction by traditional decocting method.
Clinical data
1, physical data
Be 120 examples for the examination case, all from year January in May, 2007 to 2009 the court hematology be in hospital and the out-patient, be divided at random two groups.Treatment group 60 examples, wherein, male 35 examples, female's 25 examples; 17~60 years old age, average 28.5 years old.Matched group 60 examples, wherein, male 36 examples, female's 24 examples, 18~61 years old age, average 29 years old.Two groups of patients are at aspects such as sex, age, Clinical typings, through X 2Check, the difference not statistically significant has comparability.2, case is selected
All patients is Chronic Aplastic Anemia Patients by diagnosis of hematological diseases and criterion of therapeutical effect [1] diagnosis, and it is deficient that selected case tcm diagnosis all meets Liver and kidney, the asthenia of essence and blood card, and Western medicine diagnose belongs to chronic aplastic anemia.
3, Therapeutic Method
Treatment group is taken Chinese medicine preparation of the present invention, gets Radix Codonopsis 10g, Rhizoma Atractylodis Macrocephalae 13g, Radix Rhodiolae 8g, Fructus Schisandrae Chinensis 8g, Cortex Eucommiae 11g, Radix Achyranthis Bidentatae 13g, Fructus Lycii 12g, Semen Canavaliae 6g, Semen Sesami Nigrum 9g, Flos Sophorae 13g, Rhizoma Polygonati 7g, Semen Cassiae 6g, Arillus Longan 11g.Be decocted in water for oral dose, 1 dose of every day, day takes 2 times.
Matched group is selected to reproduce and is risen the blood sheet, (Liaoyuan City Yadong Chinese medicine company limited is produced, the accurate word Z22025856 of traditional Chinese medicines, lot number: 070301) oral, 1 time 5, every day 3 times, 3 months is 1 course for the treatment of.
4, criterion of therapeutical effect
Clinical recovery: anemia and bleeding disappear, and tcm clinical practice symptom, body weight disappear substantially, and the sign integration reduces ge; 95%.Hemoglobin: male 120g/L, women 100g/L; Leukocyte 4times; 109/L; Platelet 80times; 109/L.Produce effects: anemia and bleeding are clearly better, and tcm clinical practice symptom, body weight are obviously improved, and the sign integration reduces ge; 70%.Hemoglobin: male 120g/L, women 100g/L; Leukocyte 4times; 109/L; Platelet 80times; 109/L.Effectively: anemia and bleeding take a turn for the better, and tcm clinical practice symptom, sign take a turn for the better to some extent, and the sign integration reduces ge; 30%.Before treating, the hemogram such as hemoglobin increase to some extent.Invalid: anemia and bleeding are unchanged or increase the weight of, and tcm clinical practice symptom, sign are without obviously improving or increasing the weight of, and hemogram does not reach above-mentioned standard.
5, therapeutic outcome
Two groups of curative effects relatively see Table 1; Before and after two groups of treatments, the tcm clinical practice sings and symptoms changes relatively, sees Table 2.
Table 1 liang group aplastic anemia curative effect is (n) relatively
Figure BSA00000650895000041
Two groups of aplastic anemia curative effect total effective rates compare, and difference has significance.
Before and after table 2 liang group treatment, symptom, sign disappearance improvement situation compare (n)
Two groups all are improved effect to tcm symptom, wherein Light-headedness, cardiopalmus tachypnea, soreness of the waist and knees, constipation with dry stool, two groups of comparisons of numb hand and foot symptom, and P equal 0.01 or 0.05, and difference has statistical significance, the treatment group matched group that is better than evident in efficacy.
Observed the indexs such as electrocardiogram, liver function, renal function during treatment, all changed without abnormal.
The specific embodiment
Example one: take Radix Codonopsis 10g, Rhizoma Atractylodis Macrocephalae 13g, Radix Rhodiolae 8g, Fructus Schisandrae Chinensis 8g, Cortex Eucommiae 11g, Radix Achyranthis Bidentatae 13g, Fructus Lycii 12g, Semen Canavaliae 6g, Semen Sesami Nigrum 9g, Flos Sophorae 13g, Rhizoma Polygonati 7g, Semen Cassiae 6g, Arillus Longan 11g.Be decocted in water for oral dose, 1 dose of every day, day takes 2 times.
Example two: take Radix Codonopsis 7g, Rhizoma Atractylodis Macrocephalae 15g, Radix Rhodiolae 6g, Fructus Schisandrae Chinensis 10g, Cortex Eucommiae 9g, Radix Achyranthis Bidentatae 15g, Fructus Lycii 9g, Semen Canavaliae 5g, Semen Sesami Nigrum 12g, Flos Sophorae 10g, Rhizoma Polygonati 5g, Semen Cassiae 7g, Arillus Longan 13g.Be decocted in water for oral dose, 1 dose of every day, day takes 2 times.
Example three: take Radix Codonopsis 12g, Rhizoma Atractylodis Macrocephalae 10g, Radix Rhodiolae 10g, Fructus Schisandrae Chinensis 6g, Cortex Eucommiae 13g, Radix Achyranthis Bidentatae 10g, Fructus Lycii 14g, Semen Canavaliae 7g, Semen Sesami Nigrum 7g, Flos Sophorae 15g, Rhizoma Polygonati 9g, Semen Cassiae 5g, Arillus Longan 9g.Be decocted in water for oral dose, 1 dose of every day, day takes 2 times.

Claims (2)

1. Chinese medicine preparation for the treatment of aplastic anemia is characterized in that this Chinese medicine preparation made by the Chinese medicine of following weight portion: Radix Codonopsis 7-12 part, Rhizoma Atractylodis Macrocephalae 10-15 part, Radix Rhodiolae 6-10 part, Fructus Schisandrae Chinensis 6-10 part, Cortex Eucommiae 9-13 part, Radix Achyranthis Bidentatae 10-15 part, Fructus Lycii 9-14 part, Semen Canavaliae 5-7 part, Semen Sesami Nigrum 7-12 part, Flos Sophorae 10-15 part, Rhizoma Polygonati 5-9 part, Semen Cassiae 5-7 part, Arillus Longan 9-13 part.
2. a kind of Chinese medicine preparation for the treatment of aplastic anemia according to claim 1 is characterized in that this Chinese medicine preparation made by the Chinese medicine of following weight portion: 10 parts of Radix Codonopsis, 13 parts of the Rhizoma Atractylodis Macrocephalaes, 8 parts of Radix Rhodiolaes, 8 parts of Fructus Schisandrae Chinensis, 11 parts of the Cortexs Eucommiae, 13 parts of Radix Achyranthis Bidentataes, 12 parts of Fructus Lycii, 6 parts of Semen Canavaliaes, 9 parts of Semen Sesami Nigrums, 13 parts, Flos Sophorae, 7 parts of Rhizoma Polygonatis, 6 parts of Semen Cassiaes, 11 parts of Arillus Longans.
CN 201110460080 2011-12-26 2011-12-26 Traditional Chinese medicine preparation for treating aplastic anemia Expired - Fee Related CN102512593B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110460080 CN102512593B (en) 2011-12-26 2011-12-26 Traditional Chinese medicine preparation for treating aplastic anemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110460080 CN102512593B (en) 2011-12-26 2011-12-26 Traditional Chinese medicine preparation for treating aplastic anemia

Publications (2)

Publication Number Publication Date
CN102512593A CN102512593A (en) 2012-06-27
CN102512593B true CN102512593B (en) 2013-05-08

Family

ID=46283845

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110460080 Expired - Fee Related CN102512593B (en) 2011-12-26 2011-12-26 Traditional Chinese medicine preparation for treating aplastic anemia

Country Status (1)

Country Link
CN (1) CN102512593B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104606282A (en) * 2015-03-06 2015-05-13 淄博夸克医药技术有限公司 Traditional Chinese medicine for treating anemia
CN107468899A (en) * 2017-09-25 2017-12-15 宁国平衡健康管理有限公司 One kind is enriched blood ball and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
再生障碍性贫血的研究;邵宗鸿;《基础医学与临床》;20070331;第27卷(第3期);第233-237页 *
朱强,等.中医药治疗再生障碍性贫血研究进展.《辽宁中医杂志》.2005,第32卷(第5期),第499-500页. *
邵宗鸿.再生障碍性贫血的研究.《基础医学与临床》.2007,第27卷(第3期),第233-237页.

Also Published As

Publication number Publication date
CN102512593A (en) 2012-06-27

Similar Documents

Publication Publication Date Title
CN101632819B (en) Preparation for resisting suppression of bone marrow after lung cancer chemotherapy
CN102988821B (en) Chinese medicine composition for treating carcinomatosis postoperation, postchemotherapy and postradiotherapy and preparation method of Chinese medicine composition
CN102512593B (en) Traditional Chinese medicine preparation for treating aplastic anemia
CN103845407A (en) Traditional Chinese medicine for treating chylothorax
CN105194271A (en) Traditional Chinese medicine preparation for treating advanced breast cancer by virtue of combined chemotherapy
CN102784339A (en) Medicament for treating pulmonary tuberculosis by combined chemotherapy with traditional Chinese medicine Fuying and preparation method
CN104435545B (en) A kind of Chinese medicine preparation for treating caused by benzene leukopenia
CN105456887A (en) Pharmaceutical for treating aplastic anemia
CN104398667A (en) Traditional Chinese medicinal preparation for treating leucopenia after radiotherapy
CN104147570A (en) Traditional Chinese medicine preparation for treating children with iron deficiency anemia
CN102727806B (en) Traditional Chinese medicine for treating aplastic anemia by tonifying qi
CN102284023A (en) Chinese medicinal composition for treating asthma
CN103127359B (en) TCM (traditional Chinese medicine) bone-strengthening capsule for treating senile osteoporosis
CN102727749B (en) Medicine for treating aplastic anemia
CN108567896A (en) A kind of decoction of medicinal ingredients acting on the patients such as respiratory failure
CN101953994B (en) Chinese medicament for treating luekopenia after concurrent chemoradiotherapy
CN103599397B (en) A kind of Chinese medicine composition being used for the treatment of chronic renal insufficiency
CN102755560B (en) Traditional Chinese medicine compound reducing chemotherapy side reaction and preparation method and application thereof
CN101953943A (en) Traditional Chinese medicine for treating chronic aplastic anemia
CN103330861B (en) Medicine for curing cholera and preparation method thereof
CN105362699A (en) Traditional Chinese medicine pill used for treating chronic pneumonia and preparation method
CN105687684A (en) Traditional Chinese medicine preparation for treating chronic obstructive pulmonary disease
CN104857395A (en) Medicine for treating qi-deficiency anemia and improving human body immunity and preparation method
CN105147861A (en) Traditional Chinese medicinal composition and oral preparation for treating viral skin diseases and preparation method of oral preparation
CN104491470A (en) Traditional Chinese medicine for treating cancer related anemia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130508

Termination date: 20131226